Descriptor English: | Crizotinib | ||||||
Descriptor Spanish: |
Crizotinib
| ||||||
Descriptor Portuguese: | Crizotinibe | ||||||
Descriptor French: | Crizotinib | ||||||
Entry term(s): |
PF 02341066 PF 2341066 PF-02341066 PF-2341066 PF02341066 PF2341066 Xalkori |
||||||
Tree number(s): |
D03.383.621.154 D03.383.725.050.263 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077547 | ||||||
Scope note: | A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents Protein Kinase Inhibitors |
||||||
Registry Number: | 53AH36668S | ||||||
CAS Type 1 Name: | 2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)- | ||||||
Public MeSH Note: | 2010; CRIZOTINIB was indexed under PYRAZOLES and PYRIDINES 2010-2018 |
||||||
History Note: | 2019 (2010) |
||||||
DeCS ID: | 57672 | ||||||
Unique ID: | D000077547 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/04/09 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Crizotinib
- Preferred
PF-02341066
- Narrower
Xalkori
- Narrower
Concept UI |
M0553416 |
Scope note | A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER. |
Preferred term | Crizotinib |
Concept UI |
M0549737 |
Preferred term | PF-02341066 |
Entry term(s) |
PF 02341066 PF 2341066 PF-2341066 PF02341066 PF2341066 |
Concept UI |
M0578350 |
Preferred term | Xalkori |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey